Molecular Formula | C14H10O5 |
Molar Mass | 258.2262 |
Density | 1.387±0.06 g/cm3(Predicted) |
Melting Point | 148-149 °C |
Boling Point | 437.3±45.0 °C(Predicted) |
Storage Condition | Room Temprature |
In vitro study | 3-CPs displays protective effect against UVB damage in all concentrations tested. About 50% inhibition of bacterial killing is observed when 12 ng of purified type 3 CPS is added to the OPKA. The addition of 30 μL of mouse serum post-i.p. infection with WU2 (containing 0.4 to 0.7 μg/mL released type 3 CPS) shows 26% to 52% inhibition of bacterial killing, comparable to what is observed when an equivalent amount of purified CPS is added. |
(IARC) carcinogen classification | 3 (Vol. 40, Sup 7) 1987 |
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
biological activity | 3-CPs are serotype capsular polysaccharides that can interfere with antibody-mediated bacterial killing. |